UB Paderborn / Katalog / Suche / in CDI

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Mayo Clinic proceedings, 2005-05, Vol.80 (5), p.587-595

2005

Volltextzugriff (PDF)

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Mayo Clinic proceedings, 2006-09, Vol.81 (9), p.1177-1185

2006

Volltextzugriff (PDF)

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Menopause (New York, N.Y.), 2004-07, Vol.11 (4), p.405-415

2004

Volltextzugriff (PDF)

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

JAMA : the journal of the American Medical Association, 2004-09, Vol.292 (11), p.1307

2004

Volltextzugriff (PDF)

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Clinical therapeutics, 2000-12, Vol.22 (12), p.1433-1442

2000

Volltextzugriff (PDF)

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

The American journal of cardiology, 2004-06, Vol.93 (12), p.1487-1494

2004

Volltextzugriff (PDF)

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

The American journal of geriatric pharmacotherapy, 2005-12, Vol.3 (4), p.218-228

2005

Volltextzugriff (PDF)

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (1), p.55

2004

Volltextzugriff (PDF)

Developing Drugs for Rare Diseases: Regulatory Strategies and Considerations

Drug Development for Rare Diseases, 2023, p.17-33

1, 2023

Volltextzugriff (PDF)

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Genomics (San Diego, Calif.), 2005-12, Vol.86 (6), p.648-656

2005

Volltextzugriff (PDF)

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

Current medical research and opinion, 2005-07, Vol.21 (7), p.1123-1130

2005

Volltextzugriff (PDF)

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

The American journal of gastroenterology, 2000-09, Vol.95 (9), p.2457-2457

2000

Volltextzugriff (PDF)

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Mayo Clinic proceedings, 2002-10, Vol.77 (10), p.1044-1052

2002

Volltextzugriff (PDF)

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

European heart journal, 2004-10, Vol.25 (19), p.1688-1694

2004

Volltextzugriff (PDF)

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

Clinical chemistry and laboratory medicine, 2003-09, Vol.41 (9), p.1174-1181

2003

Volltextzugriff (PDF)

Ezetimibe/Simvastatin Versus Atorvastatin for Patients Who Have Diabetes Mellitus and Hypercholesterolemia

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A235

2005

Volltextzugriff (PDF)

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

Clinical therapeutics, 2003-11, Vol.25 (11), p.2738-2753

2003

Volltextzugriff (PDF)

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A480-A481

2004

Volltextzugriff (PDF)

Dyslipidemia in patients with type 2 diabetes. Relationships between lipids, kidney disease and cardiovascular disease: Diabetes mellitus

Clinical chemistry and laboratory medicine, 2003, Vol.41 (9), p.1174-1181

2003

Volltextzugriff (PDF)

861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A302-A302

2004

Volltextzugriff (PDF)

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

The American journal of gastroenterology, 2000, Vol.95 (9), p.2457-2457

2000

Volltextzugriff (PDF)

hugs & kisses

Off our backs, 1975-03, Vol.5 (3), p.24-24

palmisano, joanne

1975

Volltextzugriff (PDF)

tampons, acacia & honey

Off our backs, 1975-02, Vol.5 (2), p.24-24

1975

Volltextzugriff (PDF)

Health and human rights in El Salvador

The New England journal of medicine, 1983-04, Vol.308 (17), p.1028

1983

Volltextzugriff (PDF)

LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD

Medscape general medicine, 2005-07, Vol.7 (3), p.3

2005

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

Developing Drugs for Rare Diseases: Regulatory Strategies and Considerations

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

Ezetimibe/Simvastatin Versus Atorvastatin for Patients Who Have Diabetes Mellitus and Hypercholesterolemia

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Dyslipidemia in patients with type 2 diabetes. Relationships between lipids, kidney disease and cardiovascular disease: Diabetes mellitus

861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

hugs & kisses

tampons, acacia & honey

Health and human rights in El Salvador

LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD

Aktive Filter

Suchergebnisse filtern